genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2010
Archemix
News
Baxter Nabs Archemix’ Lead Synthetic Hemophilia Candidate and Assets for About $30M
News
Archemix and Dicerna Ally to Develop Aptamer-Dicer Substrate RNAi Drugs
News
The Biggest R&D Collaboration Spenders in 2008
News
GSK Coughs Up $27.5M Upfront in Billion-Dollar Inflammation Deal with Archemix
News
Deerfield Makes Unsolicited Bid for NitroMed at $0.5 Per Share
News
NitroMed and Archemix to Merge
News
Archemix and Lilly Enter Aptamer Collaboration
News
Archemix Grants Ribomic Rights to Develop Aptamers for $6M Upfront
News
Archemix and NascaCell Enlarges Focus of Aptamer-Based Partnership
News
Nuvelo’s Initiation of Early-Stage Trial Triggers Milestone Payment to Archemix
1
2
Page 1 of 2
Scroll Up
Scroll Up
